Oculis
Boston, CH · 3 known investors
Oculis is a biopharmaceutical company developing pharmaceutical drug products, with a focus on ophthalmic and eye disease treatments. It conducts formulation, process, and analytical development to advance drug candidates from early research through later development stages.
Founders & leadership
RS
Riad SherifChief Executive Officer
Investors · 3
Competitors · 2
by search overlapOis38 shared keywordsOIS is a conference and community, active since 2009, focused on eye care and ophthalmology innovation, connecting startups, strategics, investors, and clinicians. It provides curated programming, networking, and access to new technologies in the ophthalmology industry.
Medscape34 shared keywordsMedscape is an online medical information platform providing clinical news, expert perspectives, case studies, quizzes, and reference material across specialties such as cardiology, oncology, neurology, and psychiatry. It serves physicians, nurses, pharmacists, residents, and medical students.
Companies competing with Oculis for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does Oculis do?
- Oculis is a biopharmaceutical company developing pharmaceutical drug products, with a focus on ophthalmic and eye disease treatments. It conducts formulation, process, and analytical development to advance drug candidates from early research through later development stages.
- Who are Oculis's investors?
- Oculis's investors include Bay City Capital, Brunnur Ventures GP, VI Partners.
- Where is Oculis headquartered?
- Oculis is headquartered in Boston, CH.